A high-throughput, automated, cell-free expression and screening platform for antibody discovery
Hunt, A. C.; Vogeli, B.; Kightlinger, W. K.; Yoesep, D. J.; Kruger, A.; Jewett, M. C.
Show abstract
Antibody discovery is bottlenecked by the individual expression and evaluation of antigen-specific hits. Here, we address this gap by developing an automated workflow combining cell-free DNA template generation, protein synthesis, and high-throughput binding measurements of antibody fragments in a process that takes hours rather than weeks. We apply this workflow to 119 published SARS-CoV-2 neutralizing antibodies and demonstrate rapid identification of the most potent antibody candidates.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A rationally designed and highly versatile epitope tag for nanobody-based purification, detection and manipulation of proteins 96%
- Engineered Reversible Inhibition of SpyCatcher Reactivity Enables Rapid Generation of Bispecific Antibodies 95%
- A Whole-Cell Screening Platform to Discover Cell Adhesion Molecules that Enable Programmable Bacterial Cell-Cell Adhesion 95%
Similar papers in this journal
Similar papers in this journal
- AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity 95%
- Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies 94%
- A novel biparatopic antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.